Should we consider ADPKD new targeted therapies in PKD2 patients? - Université de Rennes Accéder directement au contenu
Communication Dans Un Congrès Année : 2016

Should we consider ADPKD new targeted therapies in PKD2 patients?

Domaines

Immunologie

Dates et versions

hal-01326928 , version 1 (06-06-2016)

Identifiants

Citer

Emilie Cornec-Le Gall, Marie-Pierre Audrézet, Eric Renaudineau, Maryvonne Hourmant, Christophe Charasse, et al.. Should we consider ADPKD new targeted therapies in PKD2 patients?. 53rd ERA-EDTA congress, May 2016, Vienna, Austria. ⟨10.1093/ndt/gfw141.02⟩. ⟨hal-01326928⟩
104 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More